Home > NRC Library > ADAMS Public Documents

Final response to FOIA request for documents.Records subj to request encl & identified in App C.App D records being withheld in part (ref FOIA exemption 5).

Accession Number: ML20248F519

Date Released: Thursday, October 24, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20248F515 - Final response to FOIA request for documents.Records subj to request encl & identified in App C.App D records being withheld in part (ref FOIA exemption 5). (4 page(s), 5/28/1998)
• ML20248F563 - Concurs w/proposed rule amending 10CFR35 to permit medical licensees to use Pd-103 for interstitial treatment of cancer.Marked-up package presenting editorial comments encl. (8 page(s), 2/23/1989)
• ML20248F619 - Forwards notice of rulemaking of amend to 10CFR35.400,to add Pd-103 to list of brachytherapy sources as sealed source seeds for interstitial treatment of cancer. (21 page(s), 10/19/1989)
• ML20248F601 - Informs Commission that,IAW rulemaking authority delegated to EDO,EDO has signed final amend & proposes to be forwarded to Ofc of FR for publication on 891004,unless otherwise directed by Commission. (1 page(s), 9/27/1989)
• ML20248F634 - Discusses proposed amend of 10CFR35.400,adding Pd-103 for interstitial treatment of cancer,per Theragenics Corp Petition for Rulemaking PRM-35-7. (3 page(s), 2/27/1989)
• ML20248F644 - Partially deleted memo forwarding partially deleted proposed rule,to be published in FR,that amends 10CFR35, "Medical Use of Byproduct Matl." Amend would add Pd-103 as sealed source in seeds.(Partially deleted ref FOIA Exemption 5.) (15 page(s), 5/28/1998)
• ML20248F588 - Forwards mark-up copy of final rule that would amend 10CFR35,by adding palladium-103 as sealed source in seeds to list of brachytherapy sources permitted for use in treatment of cancer. (4 page(s), 7/21/1989)